Bifidobacterium Bifidum(Sun Yat-sen University)

两歧双歧杆菌(中山大学)

Report date: 2022/11/21 20:00:38

Base Information

Drug NameBifidobacterium Bifidum(Sun Yat-sen University)
Drug Alias NameN/A
ClassificationBiologicsNatural product/Extract > Microbial extract
Mechanisms of ActionImmunoglobulin E inhibitors
TargetsImmunoglobulin E
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesSun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A